Pulmonx to Present at the Citi 2023 Healthcare Conference

Rhea-AI Summary

Pulmonx Corporation (Nasdaq: LUNG), a leader in minimally invasive lung disease treatments, will participate in a fireside chat at the Citi 2023 Healthcare Conference on March 2, 2023, at 10:15 AM PT / 1:15 PM ET. The event will be accessible via a live and archived webcast on the company’s Investors section of their website.

Pulmonx is known for its Zephyr® Endobronchial Valve and related systems used extensively in treating severe emphysema/COPD, with over 100,000 valves utilized in more than 25,000 patients worldwide.

REDWOOD CITY, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Citi 2023 Healthcare Conference in New York on Thursday, March 2, 2023, at 10:15 AM PT / 1:15 PM ET.

A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for severe lung disease. Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, with over 100,000 valves used to treat more than 25,000 patients. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.

Pulmonx®, Chartis®, StratX®, and Zephyr® are registered trademarks of Pulmonx Corporation.

Contact
Brian Johnston
Gilmartin Group
investors@pulmonx.com

FAQ

When will Pulmonx participate in the Citi 2023 Healthcare Conference?

Pulmonx will participate in the Citi 2023 Healthcare Conference on March 2, 2023, at 10:15 AM PT / 1:15 PM ET.

Where can I watch the Pulmonx presentation at the Citi Healthcare Conference?

You can watch the live and archived webcast of Pulmonx's presentation on the Investors section of their website.

What is the significance of the Zephyr Valve by Pulmonx?

The Zephyr Valve is a minimally invasive treatment for severe lung disease, specifically designed for patients with severe emphysema/COPD.

How many Zephyr Valves have been used worldwide?

Over 100,000 Zephyr Valves have been used to treat more than 25,000 patients globally.

What is the ticker symbol for Pulmonx Corporation?

The ticker symbol for Pulmonx Corporation is LUNG.